Endothelial antioxidant actions of dihydropyridines and angiotensin converting enzyme inhibitors (original) (raw)

Antioxidant and Nitric Oxide-Sparing Actions of Dihydropyridines and ACE Inhibitors Differ in Human Endothelial Cells

Anke Fender

Pharmacology, 2006

View PDFchevron_right

Comparison of inhibitors of superoxide generation in vascular smooth muscle cells

Chris Wilcox

British Journal of Pharmacology, 2009

View PDFchevron_right

Synergistic Antihypertensive Effects of Nifedipine on Endothelium : Concurrent Release of NO and Scavenging of Superoxide

Leszek Kalinowski

Hypertension, 2001

View PDFchevron_right

3′,4′-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries

Chen-Huei Leo, Owen Woodman

PLoS ONE, 2011

View PDFchevron_right

Nitrosonifedipine Ameliorates the Progression of Type 2 Diabetic Nephropathy by Exerting Antioxidative Effects

Shoji Kagami

PLoS ONE, 2014

View PDFchevron_right

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells

William Weglicki

Biochemical Pharmacology, 1990

View PDFchevron_right

Vascular Oxidative Stress: Pharmacological and Nonpharmacological Approaches

Valeria CONTI

Oxidative Medicine and Cellular Longevity, 2018

View PDFchevron_right

Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619

Andrew Newby, Saima Muzaffar

Prostaglandins, leukotrienes, and essential fatty acids

View PDFchevron_right

Angiotensin-(1-7)-Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells

T. Malinski

Hypertension, 2001

View PDFchevron_right

Influence of pyridoxylidene aminoguanidine on biomarkers of the oxidative stress and selected metabolic parameters of rats with diabetes mellitus

Zuzana Orszaghova, Jana Muchová

General Physiology and Biophysics, 2009

View PDFchevron_right

Nitric oxide, a possible mediator of 1,4-dihydropyridine-induced photorelaxation of vascular smooth muscle

detlef bieger

British Journal of Pharmacology, 1996

View PDFchevron_right

Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation

Ingo Just

Arteriosclerosis, Thrombosis, and Vascular Biology, 2000

View PDFchevron_right

Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension

Vincenzo Sica

American Heart Journal, 2004

View PDFchevron_right

Diabetes and Vascular Disease: Basic Concepts of Nitric Oxide Physiology, Endothelial Dysfunction, Oxidative Stress and Therapeutic Possibilities

Verena Capellini

Current Vascular Pharmacology, 2010

View PDFchevron_right

New 1,4-Dihydropyridines Down-regulate Nitric Oxide in Animals with Streptozotocin-induced Diabetes Mellitus and Protect Deoxyribonucleic Acid against Peroxynitrite Action

Nikolajs Sjakste

Basic & Clinical Pharmacology & Toxicology, 2016

View PDFchevron_right

Targeting Oxidant Stress as a Strategy for Preventing Vascular Complications of Diabetes and Metabolic Syndrome

Toyoshi Inoguchi

Nutraceuticals, Glycemic Health and …, 2008

View PDFchevron_right

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidases

Christoph Garlichs

Cardiovascular Research, 1999

View PDFchevron_right

Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells

Gregory Dusting

Cardiovascular Research, 2007

View PDFchevron_right

Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes

Chi Kim

Diabetes, 2002

View PDFchevron_right

Vascular protective effects of dihydropyridine calcium antagonists. Involvement of endothelial nitric oxide

Anke Fender

Pharmacology, 2003

View PDFchevron_right

Angiotensin antagonist drugs as and #8220;source antioxidants and #8221; and #8211; down-regulation of NADPH oxidase activation mediates many of their protective benefits, independent of hypertension control

Charles Glassman

Oxidants and Antioxidants in Medical Science, 2015

View PDFchevron_right

Modulation of antioxidative response in the therapy of hypertension and other cardiovascular diseases

Ima Dovinova

Neuro endocrinology letters

View PDFchevron_right

The efficacy of newly synthesised agent and natural antioxidant treatment in diabetic and hypertensive rats

stanislava jankyova

View PDFchevron_right

Pharmacological induction of vascular extracellular superoxide dismutase expression in vivo

Vera Balz

Journal of Cellular and Molecular Medicine, 2009

View PDFchevron_right

Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice

Takamune Takahashi

Hypertension Research, 2012

View PDFchevron_right